Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3198613 | Journal of Allergy and Clinical Immunology | 2012 | 8 Pages |
Abstract
Treatment with ICS/LABA fixed-dose combination therapy appeared to perform as well as or better than ICS treatment alone in reducing severe asthma exacerbations; this included multiple high-risk subgroups.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Karen E. MPH, Edward L. PhD, Brian K. PhD, Richard K. PhD, Julie PhD, MCHES, L. Keoki MD, MPH,